Aligos Therapeutics
ALGS | NASDAQ
$1.66
-$0.44 (-20.95%)
At close: Nov 16, 2026, 4:00 PM ET
$1.67
+$0.01 (+0.60%)
After-hours:
Nov 16, 2026, 7:31 PM ET
Aligos Therapeutics Statistics
Key statistics explainedMarket Data
$17.37M
$-1.83M
2.42
136.63K
10.46M
0.89%
21.98%
NASDAQ
US01626L2043
Price Performance
-65.8%
-74.8%
-69.0%
-82.2%
-76.3%
-90.3%
-99.6%
-65.8%
-75.1%
-65.2%
-57.3%
Valuation
-0.26
N/A
0.00
0.01
0.56
3.20
1.54
-0.25
-0.23
-0.25
-0.06
0.04
0.03
0.03
-382.5%
-395.4%
-426.6%
Financial Health
$19.19M
$11.9M
$31.09M
$47.19M
1.77
1.77
1.05
-0.19
-0.17
-5.75
0.00
-21.91
2
Margins & Profitability
99.2%
-235.6%
-182.6%
-197.0%
-223.1%
-240.7%
16.1%
-7.9%
Returns
-140.5%
-206.3%
-251.6%
-262.9%
-140.5%
Historical Growth (CAGR)
23.4%
50.5%
N/A
-4.4%
-31.2%
N/A
10.6%
7.2%
N/A
Analyst Forecasts
Buy
1
5.4%
-28.7%
Mar 4, 2027
-$2.03
6.3%
$537.5K
218.1%
Fair Value Estimates
N/A
N/A
N/A
N/A
$20.00
1104.8%
Cash Flow
$-68.37M
$-68.66M
$-74.08M
-$6.56
-$6.54
-203.2%
Income Statement
$30.78M
$30.52M
$-72.52M
$-61.81M
$-66.29M
-$6.35
$375.33K
$-808.35K
82
Add to Watchlist
Select watchlists to add or remove ALGS